Open
Do antihypertensives improve body weight & composition more than other treatments?
Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →
Where the evidence stands
No claim has formed for this comparison yet. The trials below are registered, but none decides it.
Already under way
No registered trial that could settle this is recruiting or active.
The evidence so far
- Registered trials
- 21
- With posted results
- 2
- Published papers
- 0
Trials
- A Randomized, Open-label Study of Dapagliflozin in Patients With or Without Type 2 Diabetes Admitted With Acute Heart FailureNCT04298229 · 1 posted result
- Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction: A Pilot TrialNCT05129722
- A Double-Blind, Randomized, Active-Controlled Phase 2a Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of TriGlytza®-01 in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyNCT07139405
- Impact of Sodium-glucose Cotransporter Type 2 Inhibitors on the Course of Cardiorenal Syndrome in Acute Decompensation of Chronic Heart FailureNCT04778787
- Point-of-care Ultrasound Intervention for Tailoring Diuretic Strategy in Acute Decompensated Heart FailureNCT07469722
- Which is the Best Treatment for Non-diabetic Hypertension With Obesity: Telmisartan, Amlodipine or Candesartan, Alone or Plus MEtformin? (HOT-ACME 1)NCT00538486
- Aggressive Treatment of Metabolic Syndrome in Patients Treated With Clozapine for SchizophreniaNCT00794963 · 1 posted result
- Comparison of the Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Obese Patients With Kidney Disease: a Single Center, Prospective, Exploratory StudyNCT06344247